Johnson & Johnson MedTech acquires Laminar for $400M

Johnson & Johnson MedTech made an upfront payment of $400 million to acquire Laminar, a developer of a heart implant to reduce stroke risk. The deal includes additional milestone payments, and Laminar will join J&J's Biosense Webster division.

“Johnson & Johnson (J&J) MedTech has made an upfront payment of $400m to acquire the privately held company Laminar, a US-based developer of a heart implant that reduces the chance of stroke.”medicaldevice-network.com

• 1 source
• medicaldevice-network.comJohnson & Johnson MedTech acquires heart implant company Laminar for $400m - Medical Device NetworkRobert BarrieDec 1, 2023

Summarized from public sources; check the original articles before acting on it.